Searle & Co’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Hold |
2,606
| – | – | 0.29% | 75 |
|
|
2025
Q1 | $1.13M | Sell |
2,606
-220
| -8% | -$95.7K | 0.32% | 72 |
|
|
2024
Q4 | $1.04M | Hold |
2,826
| – | – | 0.3% | 73 |
|
|
2024
Q3 | $1.47M | Hold |
2,826
| – | – | 0.37% | 60 |
|
|
2024
Q2 | $1.53M | Buy |
2,826
+49
| +2% | +$26.6K | 0.36% | 63 |
|
|
2024
Q1 | $1.44M | Sell |
2,777
-13
| -0.5% | -$6.74K | 0.37% | 63 |
|
|
2023
Q4 | $1.32M | Sell |
2,790
-75
| -3% | -$35.4K | 0.36% | 65 |
|
|
2023
Q3 | $1.25M | Hold |
2,865
| – | – | 0.42% | 59 |
|
|
2023
Q2 | $1.35M | Buy |
2,865
+75
| +3% | +$35.4K | 0.42% | 60 |
|
|
2023
Q1 | $1.31M | Sell |
2,790
-500
| -15% | -$234K | 0.43% | 57 |
|
|
2022
Q4 | $1.69M | Hold |
3,290
| – | – | 0.58% | 50 |
|
|
2022
Q3 | $1.49M | Hold |
3,290
| – | – | 0.57% | 51 |
|
|
2022
Q2 | $1.59M | Hold |
3,290
| – | – | 0.63% | 49 |
|
|
2022
Q1 | $1.62M | Hold |
3,290
| – | – | 0.6% | 53 |
|
|
2021
Q4 | $1.53M | Hold |
3,290
| – | – | 0.55% | 57 |
|
|
2021
Q3 | $1.23M | Hold |
3,290
| – | – | 0.5% | 61 |
|
|
2021
Q2 | $1.26M | Hold |
3,290
| – | – | 0.51% | 60 |
|
|
2021
Q1 | $1.18M | Hold |
3,290
| – | – | 0.53% | 59 |
|
|
2020
Q4 | $1.06M | Hold |
3,290
| – | – | 0.51% | 58 |
|
|
2020
Q3 | $884K | Sell |
3,290
-50
| -1% | -$13.4K | 0.48% | 59 |
|
|
2020
Q2 | $878K | Hold |
3,340
| – | – | 0.51% | 56 |
|
|
2020
Q1 | $758K | Buy |
3,340
+500
| +18% | +$113K | 0.54% | 56 |
|
|
2019
Q4 | $858K | Buy |
+2,840
| New | +$858K | 0.47% | 62 |
|